DARIOHEALTH CORP (DRIO:NASDAQ)
$7.07 -0.13 (-1.8056%)
Analysed DARIOHEALTH CORP (DRIO:NASDAQ) News Sources
DarioHealth to Report First Quarter 2026 Results on Wednesday, May 13, 2026
04-05-2026
yahoo.com
Delcath Systems, Inc. (DCTH) Reports Q1 Loss, Misses Revenue Estimates
07-05-2026
yahoo.com
Si-Bone (SIBN) Reports Q1 Loss, Tops Revenue Estimates
12-05-2026
yahoo.com
DarioHealth Reports First Quarter 2026 Financial and Operating Results
13-05-2026
yahoo.com
DarioHealth Corp. (DRIO) Reports Q1 Loss, Beats Revenue Estimates
13-05-2026
yahoo.com
DarioHealth Reports Q1 2026 Results: Full Earnings Call Transcript
13-05-2026
yahoo.com
DarioHealth Q1 Earnings Call Highlights
13-05-2026
marketbeat.com
DarioHealth Corp (DRIO) Q1 2026 Earnings Call Highlights: Navigating Growth and Strategic ...
13-05-2026
yahoo.com
Dario More Than Doubles Addressable Market in Solera Health's Network via Expanded Hypertension Program, With Dario Now Reaching Greater Than 500,000 Eligible Lives
26-05-2026
yahoo.com
Dario Presents Four Studies at American Diabetes Association Scientific Sessions Highlighting Commercial and Clinical Value of its Digital Health Platform
08-06-2026
yahoo.com
What is the current price of DARIOHEALTH CORP (DRIO:NASDAQ)?
The current price of DARIOHEALTH CORP (DRIO:NASDAQ) is $7.07.
DARIOHEALTH CORP (DRIO:NASDAQ) absolute price change since previous trading day?
The absolute price change of DARIOHEALTH CORP (DRIO:NASDAQ) since the previous trading day is $-0.13.
DARIOHEALTH CORP (DRIO:NASDAQ) percentage price change since previous trading day?
The percentage price change of DARIOHEALTH CORP (DRIO:NASDAQ) since the previous trading day is -1.8056%.
What is the most recent average sentiment score for DARIOHEALTH CORP (DRIO:NASDAQ)?
The most recent average sentiment score for DARIOHEALTH CORP (DRIO:NASDAQ) is 60 out of 100.
What is the most recent average sentiment for DARIOHEALTH CORP (DRIO:NASDAQ)?
The most recent sentiment for DARIOHEALTH CORP (DRIO:NASDAQ) is .
SEC-8K** Filing Available For DARIOHEALTH CORP (DRIO:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.